We are live on
!
Find out more
AIM
Aigen Investment Management Portfolio holdings
AUM
$389M
1-Year Est. Return
16.77%
This Fund
S&P 500
This Quarter
Est. Return
+28.83%
1 Year Est. Return
+16.77%
3 Year Est. Return
+38.84%
5 Year Est. Return
+26.96%
10 Year Est. Return
–
AUM
$779M
AUM Growth
+$26.2M
(+3.5%)
Cap. Flow
-$94.9M
Cap. Flow
% of AUM
-12.17%
Top 10 Holdings %
Top 10 Hldgs %
8.33%
Holding
1,483
New
237
Increased
357
Reduced
183
Closed
706
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$5.97M |
| 2 |
Delta Air Lines
DAL
|
+$4.91M |
| 3 |
VeriSign
VRSN
|
+$4.72M |
| 4 |
Armstrong World Industries
AWI
|
+$3.93M |
| 5 |
Devon Energy
DVN
|
+$3.86M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$12.6M |
| 2 |
Microsoft
MSFT
|
+$9.18M |
| 3 |
Duke Energy
DUK
|
+$7.4M |
| 4 |
Nucor
NUE
|
+$6.45M |
| 5 |
Costco
COST
|
+$5.74M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.65% |
| 2 | Healthcare | 15.12% |
| 3 | Technology | 15.02% |
| 4 | Consumer Discretionary | 12.92% |
| 5 | Industrials | 11.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGEN
726
Agenus
AGEN
$291M
| $181K | 0.02% |
+2,344
| New | +$140K |
|
|
AFMD
727
DELISTED
Affimed
AFMD
| $168K | 0.02% |
+3,636
| New | +$101K |
|
|
TRIL
728
DELISTED
Trillium Therapeutics Inc.
TRIL
| $167K | 0.02% |
+20,636
| New | +$128K |
|
729
Vericel Corp
VCEL
$2.25B
| $164K | 0.02% |
+11,898
| New | +$161K |
|
|
SY
730
So-Young International
SY
$228M
| $160K | 0.02% |
+11,790
| New | +$125K |
|
731
BlackRock TCP Capital
TCPC
$331M
| $159K | 0.02% |
17,363
+13,964
| +411% | +$120K |
|
732
Criteo S.A. Ordinary Shares
CRTO
$902M
| $156K | 0.02% |
13,686
+12,485
| +1,040% | +$131K |
|
733
Ovid Therapeutics
OVID
$489M
| $155K | 0.02% |
+20,966
| New | +$98.1K |
|
734
Duluth Holdings
DLTH
$151M
| $150K | 0.02% |
20,298
-24,843
| -55% | -$127K |
|
735
Sportsman's Warehouse
SPWH
$46.4M
| $147K | 0.02% |
+10,348
| New | +$97.3K |
|
736
Ocular Therapeutix
OCUL
$2.03B
| $146K | 0.02% |
+17,533
| New | +$116K |
|
737
Ezcorp Inc
EZPW
$1.67B
| $140K | 0.02% |
22,196
-81,677
| -79% | -$440K |
|
738
PennantPark Floating Rate Capital
PFLT
$734M
| $138K | 0.02% |
16,465
+12,154
| +282% | +$89.2K |
|
|
VLRS
739
Controladora Vuela Compania de Aviacion
VLRS
$927M
| $137K | 0.02% |
25,967
+1,407
| +6% | +$6.64K |
|
|
ZEPP
740
Zepp Health
ZEPP
$76.1M
| $135K | 0.02% |
2,734
-1,416
| -34% | -$65.3K |
|
741
ATI
ATI
$31.1B
| $134K | 0.02% |
13,161
-52,008
| -80% | -$451K |
|
|
TPC
742
Tutor Perini Cor
TPC
$5.18B
| $133K | 0.02% |
+10,959
| New | +$98K |
|
|
ORBC
743
DELISTED
ORBCOMM, Inc.
ORBC
| $133K | 0.02% |
34,472
+33,148
| +2,504% | +$99K |
|
744
AngioDynamics
ANGO
$651M
| $131K | 0.02% |
12,849
-32,949
| -72% | -$340K |
|
|
LADR
745
Ladder Capital
LADR
$1.22B
| $131K | 0.02% |
16,197
-96,626
| -86% | -$725K |
|
746
Petrobras
PBR
$118B
| $131K | 0.02% |
+15,821
| New | +$115K |
|
747
SiriusPoint
SPNT
$2.63B
| $131K | 0.02% |
+17,430
| New | +$132K |
|
748
Frontline
FRO
$8.56B
| $120K | 0.02% |
+17,231
| New | +$146K |
|
|
TUFN
749
DELISTED
Tufin Software Technologies Ltd.
TUFN
| $120K | 0.02% |
12,593
+2,368
| +23% | +$22.6K |
|
|
PVG
750
DELISTED
PRETIUM RESOURCES INC.
PVG
| $119K | 0.02% |
14,119
-22,961
| -62% | -$187K |
|
Similar funds
SA
WCM
PFPGI
PG
SI
TCM
HBWM
DAM
Aigen Investment Management's Q2 2020 Portfolio in Review
As of Q2 2020, Aigen Investment Management held 1,483 positions worth $779M, up 3.5% from $753M the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
Aigen Investment Management withdrew a net $94.9M in Q2 2020, closing 706 positions and reducing 183 holdings. Its most notable exit was Microsoft, an estimated $9.18M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 14% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Aigen Investment Management opened a new position in Berkshire Hathaway Class B worth $5.84M.
- Aigen Investment Management's largest Q2 2020 buy was Berkshire Hathaway Class B: 32,702 shares worth $5.84M.
- Aigen Investment Management added most to Delta Air Lines in Q2 2020, an estimated $4.91M increase.
- Aigen Investment Management's biggest Q2 2020 reduction was Thermo Fisher Scientific, cutting an estimated $12.6M.
- Aigen Investment Management fully exited Microsoft in Q2 2020, selling an estimated $9.18M.
- Aigen Investment Management's ten largest holdings make up 8.3% of its $779M portfolio in Q2 2020.
- Aigen Investment Management opened 237 new positions and closed 706 in Q2 2020.
- Aigen Investment Management's portfolio value rose 3.5% quarter-over-quarter to $779M.
Based on Aigen Investment Management's 13F filing for Q2 2020, filed 10 Aug 2020.